{"url_path":"/sec/smnrw/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1913577/0001193125-26-221896-index.html","accession_number":"0001193125-26-221896","cik":"0001913577","ticker":"SMNR","issuer_name":"Semnur Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1913577/0001193125-26-221896-index.html","primary_entity_key":"0001913577","primary_entity_name":"Semnur Pharmaceuticals, Inc."},"word_count":47,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.\n\nWe did not undertake any unregistered sales of our equity securities during the three months ended March 31, 2026.\n\nWe did not repurchase any of our equity securities during the three months ended March 31, 2026."}